# FDA 483 - California Fertility Partners, A Medical Group, Professional Corporations - December 03, 2024

Source: https://www.keypedia.com/records/483/california-fertility-partners-a-medical-group-professional-corporations/d95abf7f-6f96-427f-bc63-6bb3655169ea

> FDA 483 for California Fertility Partners, A Medical Group, Professional Corporations on December 03, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: California Fertility Partners, A Medical Group, Professional Corporations
- Inspection Date: 2024-12-03
- Product Type: other
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: California Fertility Partners, a Reproductive Fertility Center in Los Angeles, was cited for failing to adequately screen oocyte and semen donors for communicable disease agents and diseases. The firm used inadequate donor history questionnaires that did not screen for critical risk factors, leading to the determination of donor eligibility and the transfer of reproductive tissues from potentially affected donors. This lapse in screening poses a significant risk, as some affected oocytes have already been transferred to recipients.

## Related Documents

- [483 - 2024-12-03](https://www.keypedia.com/records/483/california-fertility-partners-a-medical-group-professional-corporations/3d36014b-0106-4a8e-bc9a-6d935c1b865c)

## Related Officers

- [Celeta S. Coves](https://www.keypedia.com/people/celeta-s-coves/d0f63577-a6e4-4872-b06c-a024188a04ba)

Company: https://www.keypedia.com/companies/california-fertility-partners-a-medical-group-professional-corporations/028840a5-882f-4b59-9566-6438b9e103c4

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6